Related Experiment Video
Updated: Jan 17, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
EphA/EphrinA5 signaling pathway involved in the abnormal synaptic remodeling and neurotoxicity caused by
Xin Li1, Shuang Zhou2, Xiaoling Zhou3
1Department of Radiological Hygiene, General Hospital of TISCO, Sixth Hospital of Shanxi Medical University, Taiyuan, Shanxi 030003, China.
Abstract:
Benzo[a]pyrene (B[a]P) is recognized as a highly neurotoxic contaminant, however, the underlying mechanisms remain poorly understood. This study aimed to examine the alterations in erythropoietin-producing hepatocyte receptors (EphA4, EphA5) and their ligands (Ephrin A5) in the context of B[a]P-induced neurotoxicity, both in vivo and in vitro. A total of forty male mice were administered intraperitoneal injections of either a solvent (peanut oil) or a B[a]P solution (at doses of 0.5, 2, and 10 mg/kg) over a period of 60 days, once every other day. Following 30 exposures, the mice were subjected to exploratory behavioral assessments, transmission electron microscopy for hippocampal ultrastructural alterations, and western blotting to measure synapse-associated proteins (SYP, PSD95), as well as EphA4, EphA5, and Ephrin A5 proteins in the cerebral cortex. Parallel experiments were conducted using HT22 hippocampal neuronal cells. The results indicated that B[a]P treatment led to impairments in spatial cognitive function and spontaneous behavior, abnormal synaptic remodeling, and reduced SYP and PSD95 protein levels. Notably, compared to the control group, there was a marked increase in the protein levels of EphA4 and EphA5 in the cerebral cortex of mice following B[a]P treatment at mid and high doses, while Ephrin A5 protein level was significantly depressed at high dose. Additionally, in HT22 cells treated with B[a]P (0, 0.2, 2, and 20 μM) for 48 h, both cell viability and cell numbers exhibited a significant decline, accompanied by abnormal neuronal synaptic remodeling. In comparison to the control cells, EphA4 and EphA5 protein levels were significantly elevated in HT22 cells following B[a]P treatment, whereas Ephrin A5 protein levels were notably suppressed. These findings suggest that B[a]P may induce neurotoxicity through the disruption of synaptic remodeling via the EphA/EphrinA5 signaling pathway.
More Related Videos
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drugs Affecting Neurotransmitter Release or Uptake